Skip to content

Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature.

Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature in Patients Undergoing Urologic Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05636189
Enrollment
50
Registered
2022-12-05
Start date
2022-11-01
Completion date
2023-08-08
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urologic Diseases

Brief summary

Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming during induction of general anesthesia during urologic surgery.

Detailed description

Hypothermia is of continuous issue in patients undergoing general anesthesia. During urologic operation (transurethral resection of bladder and prostate), bladder irrigation worsens hypothermia. Hence, various methods including prewarming of the patient are used to maintain core temperature during operation. Prewarming is found to be effective in maintaining core temperature perioperatively by increasing peripheral tissue heat content. However, applying more than 30 minutes of prewarming may be impractical as a clinical routine practice. Hence, developing simple and effective method to prevent hypothermia is expected. Here, the investigators planned to examine the effect of active warming (10 minutes of warming during induction of general anesthesia and prewarmed intravenous fluid intraoperatively) on hypothermia in patients undergoing urologic operation under general anesthesia.

Interventions

PROCEDUREwarming during induction of anesthesia

Warming group patients are applied air-forced warming device (bair-hugger 43'C) with blanket (warm touch, COVIDIEN, full body blanket) during induction of anesthesia in the operation room.

PROCEDUREPrewarmed intravenous fluid administration

Prewarmed intravenous fluid is connected.

Sponsors

Inje University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* patients undergoing urologic surgery(transurethral resection of bladder, prostate)

Exclusion criteria

* moderate to severe cardiopulmonary, renal impairment * previous thyroid disease * any infection sign * abnormal temperature prior to induction of general anesthesia (\<36'C or \>37.5'C) * refusal to participate in the study * unable to understand the study

Design outcomes

Primary

MeasureTime frameDescription
incidence of hypothermia at the end of the operationapproximately 1-2hours after induction (at the end of operation)number of patients with hypothermia (\<36'C) using esophageal stethoscope will be recorded.

Secondary

MeasureTime frameDescription
change in temperature drop before and end of operationon arrival at the OR upto 1-2hours after induction (at the end of the operation)change in core temperature will be observed
thermal comfortupto 1hour after end of the operation (at discharge of postanesthesia care unit)thermal comfort scale ( 0= very cold, 5= fine, 10= very hot and uncomfortable) will be used.
incidence of shiveringupto 1 hour after end of the operation (on arrival at the postanesthesia care unit)4 point shivering scale (0=none, 1=core and neck shivering, 2= upper extremity 3= whole body) will be used.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026